Picture of Uni-Bio Science logo

690 Uni-Bio Science Share Price

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapContrarian

Momentum

Relative Strength (%)
1m-10.66%
3m+23.46%
6m-25.02%
1yr+5.4%
Volume Change (%)
10d/3m-48.85%
Price vs... (%)
52w High-40.37%
50d MA-5.25%
200d MA-11.63%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital28.38%
Return on Equity36.79%
Operating Margin20.59%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Uni-Bio Science EPS forecast chart

Profile Summary

Uni-Bio Science Group Limited is a Hong Kong-based investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company operates through four segments. In-house Chemical Pharmaceutical Products segment is engaged in the manufacture and sales of in-house chemical pharmaceutical products. Its chemical pharmaceutical products include Pinapu, among others. In-house Biological Pharmaceutical Products segment is engaged in the manufacture and sales of in-house biological pharmaceutical products. Its biological pharmaceutical products include GeneTime and GeneSoft, among others. In-house Biological Pipeline segment is engaged in the industrialization of in-house biological pipeline. Its biological pipeline products include Uni-E4 and Uni-PTH, among others. Third-party Pharmaceutical Products segment is engaged in the sales of third-party pharmaceutical products.

Directors

Last Annual
December 31st, 2023
Last Interim
June 30th, 2024
Incorporated
February 20th, 2001
Public Since
November 12th, 2001
No. of Employees
458
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
hk flag iconStock Exchange of Hong Kong Limited
Shares in Issue
6,163,588,147

690 Share Price Performance

Upcoming Events for 690

Similar to 690

Picture of 3D Medicines logo

3D Medicines

hk flag iconStock Exchange of Hong Kong Limited

Picture of 3SBio logo

3SBio

hk flag iconStock Exchange of Hong Kong Limited

Picture of AIM Vaccine Co logo

AIM Vaccine Co

hk flag iconStock Exchange of Hong Kong Limited

Picture of Ascletis Pharma logo

Ascletis Pharma

hk flag iconStock Exchange of Hong Kong Limited

Picture of Asymchem Laboratories Tianjin Co logo

Asymchem Laboratories Tianjin Co

hk flag iconStock Exchange of Hong Kong Limited

FAQ